Claritas Pharmaceuticals, Inc.
CLAZF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $1 | $0 |
| Inventory | $0 | -$0 | -$0 | -$0 |
| Other Curr. Assets | $1 | $0 | $0 | $0 |
| Total Curr. Assets | $1 | $0 | $1 | $4 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $2 | $5 | $9 | $11 |
| Intangibles | $8 | $20 | $49 | $50 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | -$0 |
| Total NC Assets | $9 | $25 | $59 | $61 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10 | $25 | $60 | $65 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $1 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | -$1 | -$2 | -$2 | $0 |
| Other Curr. Liab. | $5 | $4 | $6 | $3 |
| Total Curr. Liab. | $7 | $6 | $8 | $4 |
| LT Debt | $0 | $0 | $0 | $3 |
| Deferred Rev, NC | $0 | $3 | $0 | $17 |
| Deferred Tax Liab, NC | $2 | $7 | $11 | $11 |
| Other NC Liab. | $0 | $13 | $31 | $53 |
| Total NC Liab. | $2 | $23 | $42 | $73 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9 | $29 | $50 | $77 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $57 | $56 | $44 | $29 |
| Retained Earnings | -$55 | -$59 | -$38 | -$45 |
| AOCI | $57 | $56 | $48 | $33 |
| Other Equity | $0 | $56 | -$44 | $4 |
| Total Equity | $2 | -$3 | $10 | -$12 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10 | $25 | $60 | $65 |
| Net Debt | $1 | $1 | $0 | -$1 |